Concord Biotech up 24% in debut, nets over $1 billion in valuation
India's Concord Biotech saw a 24.6% surge in its share prices to Rs 923 on Friday. With the biopharma company's IPO initially priced at Rs 741 rupees, its valuation is now at $1.16bn. The IPO was made up of 20.9 million shares from existing stakeholders, and subscribed 24.87 times as of the final day of bidding in August.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
